Treatment of phantom bite syndrome with milnacipran - A case series

Neuropsychiatric Disease and Treatment

Volumn 2, Issue 3, 2006, Pages 387-390

  Toyofuku, Akira ^a,b   Kikuta, Toshihiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Occlusal discomfort milnacipran oral psychosomatic disorders; Phantom bite syndrome

Indexed keywords

MILNACIPRAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DENTITION; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HUMAN; MALE; MOUTH DISCOMFORT; NAUSEA; PHANTOM BITE SYNDROME; PSYCHOSOMATIC DISORDER; SENSORY DYSFUNCTION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL ANALOG SCALE;

EID: 33750022342     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2006.2.3.387     Document Type: Article

References (14)

1. Bieri D, Reeve RA, Champion GD, et al. 1990 The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain, 41:139-50.
2. Briley M. 2003. New hope in the treatment of painful symptoms in depression. Curr Opin Investig Drugs, 4:42-5.
3. Briley M. 2004. Clinical experience with dual action antidepressants in different chronic pain syndromes. Hum Psychopharmacol Clin Exp, 19:S21-5.
4. Jagger RG, Korszun A. 2004. Phantom bite revisited. Br Dent J, 197:241-3.
5. Marbach JJ. 1976. Phantom bite. Am J Orthod, 70:190-9.
6. Marbach JJ. 1978. Phantom bite syndrome. Am J Psychiatry, 135:476-9.
7. Marbach JJ, Varoscak JR, Blank RT, et al. 1983. "Phantom bite": classification and treatment. J Prosthet Dent, 49: 556-9.
8. Marbach JJ. 1996. Orofacial phantom pain: theory and phenomenology. J Am Dent Assoc, 127:221-9.
9. Stahl S, Briley M. 2004. Understanding pain in depression. Hum Psychopharmacol Clin Exp, 19:S9-13.
10. Toyofuku A. 2000. A clinical study on the psychosomatic approaches in the treatment of serious oral psychosomatic disorders under hospitalization: Evaluation of "Behaviour restriction therapy" for oral psychosomatic disorders and consideration of its pathophysiology [Japanese]. Jpn J Psycosom Dentist, 15:41-71.
11. Toyofuku A. 2003. Efficacy of milnacipran for glossodynia patients. Int J Psych Clin Pract, 7(Suppl 1):23-4.
12. Toyofuku A, Miyako H. 2004. A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran. Hum Psychopharmacol, 19:357-8.
13. Toyofuku A, Umemoto J, Saiki M, et al. 2003. Clinical experiences with the use of milnacipran in the treatment of oral psychosomatic disorders [Japanese]. Jpn J Psycosom Dentist, 18:99-101.
14. Vitton O, Gendreau M, Gendreau J, et al. 2004. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol, 19(Suppl 1):S27-35.